John Nicholson

2015

In 2015, John Nicholson earned a total compensation of $2M as Senior Vice President and Chief Financial Officer at Nektar Therapeutics, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$267,500
Option Awards$319,528
Salary$563,100
Stock Awards$808,594
Other$12,661
Total$1,971,383

Nicholson received $808.6K in stock awards, accounting for 41% of the total pay in 2015.

Nicholson also received $267.5K in non-equity incentive plan, $319.5K in option awards, $563.1K in salary and $12.7K in other compensation.

Rankings

In 2015, John Nicholson's compensation ranked 4,780th out of 13,638 executives tracked by ExecPay. In other words, Nicholson earned more than 65.0% of executives.

ClassificationRankingPercentile
All
4,780
out of 13,638
65th
Division
Manufacturing
1,757
out of 5,187
66th
Major group
Chemicals And Allied Products
628
out of 1,857
66th
Industry group
Drugs
498
out of 1,531
68th
Industry
Pharmaceutical Preparations
395
out of 1,179
67th
Source: SEC filing on April 29, 2016.

Nicholson's colleagues

We found five more compensation records of executives who worked with John Nicholson at Nektar Therapeutics in 2015.

2015

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2015

Gil Labrucherie

Nektar Therapeutics

General Counsel

2015

Maninder Hora

Nektar Therapeutics

Senior Vice President Pharmaceutical Development and Manufacturing Operations

2015

Ivan Gergel

Nektar Therapeutics

Chief Medical Officer

2015

Stephen Doberstein

Nektar Therapeutics

Senior Vice President and Chief Research and Development Officer

You may also like